Kyle Billeter
Regional Business Director @ADC Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
Regional Business Director @ADC Therapeutics
Phoenix, AZ, US
Regional Business Director – Rare Hematology | ADC Therapeutics• Built and led ADCT’s inaugural hematology sales team (8 HTSs) across the South-Central Region• Launched Zynlonta (ADC) in relapsed/refractory DLBCL, delivering rapid uptake across top academic and community centers• Led region responsible for ADCT’s first-ever commercial patient• Activated 100+ accounts, including 100% of NCCN/NCI-designated centers• Achieved 2022 Summit Award as top performing region nationally• Developed and promoted internal talent while maintaining lowest attrition rate in the organization
EDUCATION
Northern Arizona University
B.S., Criminal Justice
SKILLS
ABOUT KYLE BILLETER
I am a senior commercial leader with 25+ years of success building and leading high-performing oncology and rare disease teams across first-in-class launches, mature brands, and complex academic markets.Currently, I serve as Regional Business Director at ADC Therapeutics, where I built and lead an eight-person Hematology Therapeutic Specialist team responsible for the launch of Zynlonta in relapsed/refractory DLBCL. Our region delivered ADCT\'s first-ever commercial patient, achieved full NCCN/NCI center activation, and earned the 2022 Summit Award as the top region nationally.My leadership style is grounded in talent development, accountability, and culture. I have recruited, developed, and retained top commercial talent - achieving the lowest attrition rate in the nation while advancing multiple team members into expanded roles.I\'m passionate about bringing innovative therapies to patients with rare and life-threatening cancers and partnering cross-functionally to shape commercial strategy, field structure, and organizational culture as companies scale.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.